These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36939482)

  • 21. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
    Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended frequency range hearing thresholds and otoacoustic emissions in acute acoustic trauma.
    Büchler M; Kompis M; Hotz MA
    Otol Neurotol; 2012 Oct; 33(8):1315-22. PubMed ID: 22931865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of aging on distortion-product otoacoustic emissions in adults with normal hearing.
    Uchida Y; Ando F; Shimokata H; Sugiura S; Ueda H; Nakashima T
    Ear Hear; 2008 Apr; 29(2):176-84. PubMed ID: 18595184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cisplatin on distortion product otoacoustic emissions in Japanese patients.
    Eiamprapai P; Yamamoto N; Hiraumi H; Ogino-Nishimura E; Kitamura M; Hirano S; Ito J
    Laryngoscope; 2012 Jun; 122(6):1392-6. PubMed ID: 22555987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of hearing threshold levels and distortion product otoacoustic emissions among noise exposed young adults.
    Seixas NS; Kujawa SG; Norton S; Sheppard L; Neitzel R; Slee A
    Occup Environ Med; 2004 Nov; 61(11):899-907. PubMed ID: 15477283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.
    Magliulo G; Cianfrone G; Triches L; Altissimi G; D'Amico R
    Laryngoscope; 2001 Jan; 111(1):102-9. PubMed ID: 11192876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with osteoporosis have higher incidence of sensorineural hearing loss.
    Kahveci OK; Demirdal US; Yücedag F; Cerci U
    Clin Otolaryngol; 2014 Jun; 39(3):145-9. PubMed ID: 24716511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C.
    Casale M; Mazzarelli C; Vespasiani Gentilucci U; Potena M; Pappacena M; Faiella F; Galati G; Salvinelli F; Picardi A
    Int J Immunopathol Pharmacol; 2012; 25(2):551-6. PubMed ID: 22697091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions.
    Riga M; Psarommatis I; Korres S; Lyra Ch; Papadeas E; Varvutsi M; Ferekidis E; Apostolopoulos N
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1003-8. PubMed ID: 16359737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of distortion product otoacoustic emissions and pure tone audiometry in occupational screening for auditory deficit due to noise exposure.
    Wooles N; Mulheran M; Bray P; Brewster M; Banerjee AR
    J Laryngol Otol; 2015 Dec; 129(12):1174-81. PubMed ID: 26549131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auditory Outcomes in Patients Who Received Proton Radiotherapy for Craniopharyngioma.
    Bass JK; Huang J; Hua CH; Bhagat SP; Mendel LL; Onar-Thomas A; Indelicato DJ; Merchant TE
    Am J Audiol; 2018 Sep; 27(3):306-315. PubMed ID: 30073327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between distortion product otoacoustic emissions and frequency modulation difference limens.
    Krishnamurti S
    Ear Hear; 2000 Aug; 21(4):305-9. PubMed ID: 10981606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distortion Product Otoacoustic Emissions in Screening for Early Stages of High-frequency Hearing Loss in Adolescents.
    Paping DE; van der Schroef M; Helleman HW; Goedegebure A; Baatenburg de Jong RJ; Vroegop JL
    Noise Health; 2022; 24(112):20-26. PubMed ID: 35645136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Dinopoulou D; Vossinakis I; Tsakanikos M; Douniadakis D
    Int J Pediatr Otorhinolaryngol; 1999 Nov; 50(3):177-84. PubMed ID: 10595663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Hearing Loss Among a Representative Sample of Canadian Children and Adolescents, 3 to 19 Years of Age.
    Feder KP; Michaud D; McNamee J; Fitzpatrick E; Ramage-Morin P; Beauregard Y
    Ear Hear; 2017; 38(1):7-20. PubMed ID: 27556530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended High-Frequency Audiometry for Ototoxicity Monitoring: A Longitudinal Evaluation of Drug-Resistant Tuberculosis Treatment.
    Stevenson LJ; Biagio-de Jager L; Graham MA; Swanepoel W
    Am J Audiol; 2023 Mar; 32(1):70-80. PubMed ID: 36490390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA).
    Konrad-Martin D; Reavis KM; McMillan G; Helt WJ; Dille M
    J Rehabil Res Dev; 2014; 51(1):81-100. PubMed ID: 24805896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.
    Geyer LB; Menna Barreto SS; Weigert LL; Teixeira AR
    Braz J Otorhinolaryngol; 2015; 81(6):589-97. PubMed ID: 26480907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpreting auditory brainstem evoked responses and distortion product otoacoustic emissions in diabetic patients with normal hearing.
    Cho WK; Kang WS; Lee JB; Park HJ; Chung JW; Ahn JH
    Auris Nasus Larynx; 2021 Apr; 48(2):227-234. PubMed ID: 32921527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.